文献速递毛发、甲与色素性疾病

角质形成细胞锚定生物制剂实现小鼠白癜风精准定位治疗

A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo.
PubMed 文献 · J Invest Dermatol · 2022-07-02

研究开发一种双特异性抗体,可阻断IFN-γ信号并结合角质形成细胞的桥粒芯蛋白。在体外、离体及小鼠白癜风模型中,该抗体较非锚定版本皮肤滞留更久、血中清除更快、全身IFN-γ抑制更少,且几乎仅对治疗侧足垫提供局部保护。

要点

  • 角质形成细胞是白癜风中放大IFN-γ信号的关键细胞。
  • 角质形成细胞锚定双特异性抗体较非锚定版本皮肤滞留改善、血中清除更快。
  • 该抗体几乎仅对治疗侧足垫提供局部保护,显著减少组织外IFN-γ阻断效应。

核心结论

  • 角质形成细胞锚定有效且显著减少IFN-γ阻断的组织外效应,为包括白癜风在内的局部性皮肤病提供更安全的治疗策略。

研究设计与样本

  • 研究在体外、离体和小鼠白癜风模型中对双特异性抗体进行表征。
  • 双特异性抗体可阻断IFN-γ信号并结合角质形成细胞表达的桥粒芯蛋白。
  • 局部足垫注射后行单光子发射计算机断层扫描/计算机断层扫描生物分布和血清检测。

主要发现

  • 双特异性抗体较非锚定版本皮肤滞留改善、血中清除更快、全身IFN-γ抑制更少。
  • 双特异性抗体在白癜风期间几乎仅对治疗侧足垫提供局部保护。
  • 局部注射非锚定抗IFN-γ抗体无法实现上述局部保护。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the central role of IFN-γ in vitiligo pathogenesis, systemic IFN-γ neutralization is an impractical treatment option owing to strong immunosuppression. However, most patients with vitiligo present with <20% affected body surface area, which provides an opportunity for localized treatments that avoid systemic side effects. After identifying keratinocytes as key cells that amplify IFN-γ signaling during vitiligo, we hypothesized that tethering an IFN-γ‒neutralizing antibody to keratinocytes would limit anti‒IFN-γ effects on the treated skin for the localized treatment. To that end, we developed a bispecific antibody capable of blocking IFN-γ signaling while binding to desmoglein expressed by keratinocytes. We characterized the effect of the bispecific antibody in vitro, ex vivo, and in a mouse model of vitiligo. Single-photon emission computed tomography/computed tomography biodistribution and serum assays after local footpad injection revealed that the bispecific antibody had improved skin retention, faster elimination from the blood, and less systemic IFN-γ inhibition than the nontethered version. Furthermore, the bispecific antibody conferred localized protection almost exclusively to the treated footpad during vitiligo, which was not possible by local injection of the nontethered anti‒IFN-γ antibody. Thus, keratinocyte tethering proved effective while significantly diminishing the off-tissue effects of IFN-γ blockade, offering a safer treatment strategy for localized skin diseases, including vitiligo.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Hsueh YC, Wang Y, Riding RL, et al. A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo. J Invest Dermatol. 2022. PMID: 35787400. doi:10.1016/j.jid.2022.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。